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A clinico-pathologic study of crescentic glomerulonephritis in
50 children. A report of the Southwest Pediatric Nephrology
Study Group'
A clinico-pathologic study of crescentic glomerulonephritis in 50 chil-
dren. A report of the Southwest Pediatric Nephrology Study Group. In
this study, we have evaluated 50 children (30 girls and 20 boys; mean
age, 10.1 years) with a variety of renal diseases in whom renal biopsy
specimens showed crescents in  50% of glomeruli. Initial clinical
features included edema in 61%; hypertension in 51%; gross hematuria
in 73%; 3 to 4 + proteinuria in 78%; and severely decreased GFR (< 30
mI/mm/i .73 m2) in 66%. When the total number of patients was divided
into those with 50 to 79% crescents (N = 18) and those with 80 to 100%
crescents (N = 32), no significant difference in outcome could be
demonstrated, with endstage renal disease (ESRD) being seen in 44 and
52% of the two groups, respectively. Pathologic features associated
with a poor prognosis included predominance of large crescents (P =
0.004) or fibrous crescents (P = 0.03); increased frequency of gaps in
Bowman's capsule (P = 0.004); global giomerular sclerosis (P = 0.05);
glomerular 1gM (P = 0.003); interstitial fibrosis (P = 0.03); and tubular
atrophy (P = 0.04). At followup, GFR was normal in all patients with
poststreptococcal GN, but low in 60% of patients with other conditions.
The study permits the following conclusions: (1) Approximately 50% of
children with crescents in 50% or more glomeruli progress to ESRD; (2)
a poor prognosis is associated with (a) a high percentage of large
crescents, (b) increased frequency of gaps in Bowman's capsule, and (c)
evidence of chronic histologic changes, but not with the percentage of
crescents per se; and (3) the underlying type of glomerulonephritis is
considered a helpful prognostic indicator. This study also suggests that
gaps in Bowman's capsule may play a role in the fibrous transformation
of the glomerular crescents.
Une étude anatomo-clinique de Ia glomerulonéphrite a croissants chez
50 enfants. Un rapport du Southwest Pediatric Nephrology Study Group.
Dans cette Ctude, nous avons évalué 50 enfants (30 flues et 20 garcons;
age moyen, 10,1 ans) atteints de diverses maladies rénales, chez
lesquels des specimens biopsies rénales ont montré des croissants dans
50% des glomérules. Les caractéristiques cliniques initiales comprenai-
ent des oedèmes chez 61%; une hypertension chez 51%; une hématurie
macroscopique chez 73%; une protéinurie 3 a 4 + chez 78%; et une
GFR sévèrement diminuée (< 30 mlIminIl ,73 m2) chez 66%. Lorsque le
nombre total de malades était divisé en ceux ayant 50 a 79% de
croissants (N = 18) et ceux ayant 80 a 100% de croissants (N = 32),
aucune difference significative dans le devenir ne pouvait être
démontrée, une insuffisance rénale terminale (ESRD) étant observée
chez 44 et 52% des deux groupes, respectivement. Les caracteristiques
anatomo-pathologiques associées a un mauvais pronostic comprenaient
Ia predominance de grands croissants (P = 0,004), ou de croissants
fibreux (P = 0,03); une augmentation de frCquence de lacunes dans Ia
capsule de Bowman (P = 0,004); une sclérose glomérulaire globale (P
= 0,05); des 1gM glomérulaires (P = 0,003); fibrose interstitielle (P
0,03); et une atrophie tubulaire (P = 0,04). Lors du suivi, GFR était
normale chez tous les malades atteints de GN post-streptococcal, et
basse chez 60% des malades ayant d'autres atteintes. Cette etude
autorise les conditions suivantes: (1) approximativement 50% des
enfants ayant des croissants dans 50% ou plus des glomérules évoluent
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vers l'ESRD; (2) un mauvais pronostic est associé a (a) un fort
pourcentage de grands croissants, (b) une augmentation de frequence
de lacunes dans Ia capsule de Bowman, et (c) Ia preuve de modifications
histologiques chroniques, mais non au pourcentage de croissants per Se;
et (3) le type de glomérulonéphrite sous-jacente est considdré comme un
indicateur pronostique utile. Cette étude suggère aussi que les lacunes
de la capsule de Bowman pourraient jouer un role dans Ia transforma-
tion fibreuse des croissants glomerulaires.
The presence of extensive crescents in renal biopsy speci-
mens of both adults and children is usually considered to be
indicative of a poor prognosis [1—3]. Some authors conclude
that the outcome of such patients depends more on the number
of crescents than the underlying glomerulopathy [1, 4, Si and
that it is much worse when the crescents affect 80% or more
glomeruli [2, 3, 6]. Others suggest that the outcome is influ-
enced more by the type of underlying glomerular disease than
the extent of crescent formation per se [7—91. The latter view
has received support from the excellent outcome observed in
many children with poststreptococcal crescentic glomerulo-
nephritis [71, although even this has been disputed by some
studies [10, 11].
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Table 1. Clinical and laboratory data compiled in children with crescentic glomerulonephritis
Clinical and laboratory features
1. Age
2. Sex
3. Race
4. Blood pressure
5. Edema
6. Estimate of glomerular filtra-
tion rate
7. Serum ANA
8. Serum albumin
9. Hematuria, seventy
10. Proteinuria, semiquantitative
11. Pre-biopsy treatment with
Steroids
Cytotoxic drugs
Anticoagulants
12. Serum complement (C3)
I. Glomeruli with crescents—percentage
2. Type of crescent—cellular, fibrocellular,
fibrous—percentage of each
3. Size of crescent—small, medium, large—
percentage of each
4. Crescents in different stages—percentage
5. Gaps in Bowman's capsule in glomeruli
with cellular, fibrocellular and fibrous—
percentage of each
6. Presence of polys and necrosis in crescents,
and glomerular tuft
7. Glomerular tuft hypercellularity
8. Mesangial matrix increase
9. Glomerular basement membrane thickening
10. Glomerular capillary lumen obliteration
11. Glomerular lobulation
12. Gaps in glomerular basement membranes
13. Global glomerulosclerosis
14. Tubulointerstitial disease
15. Blood vessels—vasculitis
—arteriosclerosis
16. Immunofluorescence—presence and location of
IgG, 1gM, IgA, C3, Cl or C4, and fibrinogen-
related antigen (FRA)
17. Ultrastructure
Presence and localization of electron dense
deposits
Presence/absence of fibrin
In the present study, members of the Southwest Pediatric
Nephrology Study Group (SPNSG) have used strict criteria in
re-evaluating a variety of clinical and pathologic lesions in
children with crescentic glomerulonephritis. We performed a
standardized semiquantitative assessment of the pathologic
features on renal biopsy specimens of a large number of
children with crescentic glomerulonephritis, and evaluated a
number of pathologic and clinical variables as possible indica-
tors of the subsequent clinical course of the children.
Methods
Patient population
Patients were initially accepted into the study if they had a
renal biopsy specimen that demonstrated crescents in at least
50% of glomeruli available for study. There was no attempt to
evaluate patients with any specific type of underlying glomer-
ular lesions, nor was any excluded. Detailed clinical question-
naires were completed by clinicians at the individual SPNSG
centers. Final acceptance of patients was based on the presence
of the pathologic lesion described above and the completion of
the questionnaire pertaining to the clinical history.
Clinical and laboratory studies
Clinical and laboratory data that were collected on each of
the patients are shown in Table 1. The data were extracted from
two time periods during the clinical course: (1) prior to the
diagnostic renal biopsy and (2) at the time of latest followup in
patients who have not progressed to endstage renal disease
(ESRD), or on the date that ESRD was established in the other
patients.
Hypertension was defined as a diastolic blood pressure
greater than the 95th percentile for age, based on the Pediatric
Task Force Recommendations [121, or a diastolic pressure
greater than 90 mm Hg. Proteinuria was evaluated by dipstick
estimation, by 24-hr quantitative measurement, or both. The
nephrotic syndrome (NS) was defined as proteinuria ( 2 +
qualitative proteinuria by dipstick, or  40 mglm2/hr), serum
albumin less than 2.5 gldl, and edema. Hematuria was defined
as positive ii blood was present by dipstick or if microscopic
examination showed equal to or greater than 5 red blood cells
per high power field, and gross, if visible with the naked eye.
Glomerular ifitration rate (GFR) (ml/min/l .73 m2) was esti-
mated as inulin, creatinine, or sodium iothalomate (Glofil)
clearance when one of these procedures was carried out, but
otherwise calculated from the formula [131:
GFR (ml/minll.73 m2) = 0.55
x body length (cm)/serum creatinine (mgldl)
GFR was then coded for each patient as normal (> 90), mild
reduction (60 to 90), moderate reduction (30 to 60), or severe
reduction (< 30). Endstage renal disease (ESRD) was de-
fined when a patient required chronic dialysis or renal
transplantation.
Serum concentrations of creatinine, albumin and C3, and
serum antinuclear antibody levels (ANA) were performed at
each institution using local laboratory methods.
Pathologic studies
Renal biopsy specimens were studied by both light micros-
copy and either immunofluorescence or electron microscopy in
all but one patient. Forty specimens were studied with all three
methods.
Light microscopic studies were performed in all 50 patients
on renal tissue samples that had been fixed in Dubosq-Brasil,
Zenker's or 10% formalin solution, embedded in either paraffin
or plastic and cut into thin sections by routine methods at each
participating institution. Sections were stained with hematoxy-
lin and eosin, periodic acid-Schiff, silver methenamine and
Masson's trichrome. Selected slides (mean, 3; range, 1 to 7)
were evaluated by SPNSG pathologists with respect to the
severity and distribution of individual pathologic features in the
glomeruli, tubules, interstitium, and arteries as listed in Table 1.
Abnormalities were graded semiquantitatively on a 0 to 3+
scale similar to methods previously described by Pirani, Salinas-
Madrigal, and Koss [14] and utilized in our previous studies [15,
161. The SPNSG pathologists reviewed the material indepen-
dently and without knowledge of the patient's clinical course;
they tabulated the results on a renal biopsy checklist that had
been prepared previously. Following the compilation of these
data, the patients were divided into two groups according to the
Pathologic features
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percentage of glomeruli with crescents: group 1, 50 to 79% of
the glomeruli with crescents and group 2, 80 to 100% of the
glomeruli with crescents. The mean number of glomeruli in all
50 biopsy specimens was 22 (range, 5 to 100), with 47 biopsy
specimens having eight or more glomeruli. The mean number of
glomeruli in group 1 was 23 and in group 2 was 21 (P 0.59).
Histologic definitions
The glomerular crescents were classified as small, medium,
or large as follows:
Small crescent—a crescent involving 10 to 50% of the
glomerular circumference. (Fig. 1)
Medium crescent—a crescent involving 50 to 80% of the
glomerular circumference. (Fig. 2)
Large crescent—a crescent involving more than 80% of the
glomerular circumference. (Fig. 3)
The crescents were defined as cellular, fibrocellular, or
fibrous using the following definitions which were modified
from the World Health Organization classification of renal
disease of Churg et a! [171:
Cellular crescent—presence of cells filling part or all of the
Bowman's space. Minimum requirement for this definition was
the presence of at least two layers of cells in addition to the
visceral and parietal epithelium with involvement of at least
10% of the glomerular circumference. (Figs. 1, 2, and 3)
Fibrocellular crescent—a lesion similar to a cellular crescent
but with the addition of a variable amount of fibrillar material.
This fibrillar material may be either basement-membrane-like
material or collagen; it was assessed using the silver
methenamine and especially the trichrome stains (Fig. 4).
Fibrous crescent—a lesion within the Bowman's space com-
posed predominantly of fibrous tissue (with tinctorial features
of collagen). This lesion, which may represent scarred remains
of cellular and fibrocellular crescents, was also assessed utiliz-
ing the trichrome stain.
Crescents in d/ferent stages—a single glomerulus containing
two distinct types of crescent (cellular, fibrocellular, or fibrous).
Bowman's capsule gaps (BCG)—focal breaks in the basal
lamina of Bowman's capsule identified by silver methenamine
and PAS-stained sections (Fig. 4). The presence of BCG was
determined individually on all glomeruli with cellular, fibrocel-
lular, and fibrous crescents.
Glomerular mesangial hypercellularity—three or more cells
in a peripheral mesangial region in a thin light microscopic
section; allowance was made for the variation in slide section
thickness among biopsy specimens, and the grading was per-
formed in glomeruli showing the least compression by cres-
cents. Semiquantitative estimates were defined as 1 + = 3 to 4
cells/mesangial region, 2 + = S to 6 cells/mesangial region, and
3+ = more than 6 cells/mesangial region.
The number of polymorphonuclear leukocytes (polys) present
per glomerular tuft cross-section was determined in the same
fashion with I + = 3 to 4 polys/glomerulus, 2 + = 5 to 6
polys/glomerulus, and 3+ = 8 or more polys/glomerulus.
Glomerular capillary loop obliteration—defined as the ab-
sence of a visible lumen and graded as 1 + = 20% or less of the
glomerular capillaries closed, 2 + = 20 to 60% of the glomerular
capillaries closed, and 3 + = more than 60% of the glomerular
capillaries closed.
Fig. 1. (Top) Light microscopy showing a glomerulus with a small
cellular crescent (arrow). Several polymorphonuclear leukocytes are
seen in the capillary lumens. (Penodic-acid-Methenamine silver,
x 250). Fig. 2. (Middle) Light microscopy showing a glomerulus with a
medium cellular crescent. Several polymorphonuclear leukocytes are
seen in the capillary lumens and in the crescent. (Periodic-acid-
Methenamine silver, x 250). Fig. 3. (Bottom) Light microscopy showing
a glomerulus with a large cellular crescent. Several polymorphonuclear
leukocytes are seen in the capillary lumens and in the crescent.
(Penodic-acid-Methenamine silver, x 250)
Glomerular lobulation—prominence of glomerular lobules
and graded on a semiquantitative scale from 0 to 3+ defined as
1+ = mild, 2 + = moderate, and 3+ = severe.
Tubular atrophy and interstitialfibrosis were graded 0 to 3+,
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Table 2. Types of diseases in 50 children with crescentic
glomerulonephritis
Nonspecified immune complex diseas& 13
Systemic lupus erythematosus 9
Idiopathic (no evidence of immune complexes) 7
Poststreptococcal glomerulonephritis 6
IgA nephropathy 4
Henoch-Schönlein purpura 3
Vasculitis 3
Possible anti-glomerular basement membrane diseaseb 3
Dense deposit disease 2
a Nonspecified immune complex disease is defined as the presence of
glomerular electron dense deposits in the absence of any other features
of systemic disease.
b These three cases had marked linear glomerular basement mem-
brane staining of IgG but no documentation of circulating anti-GBM
antibodies.
Fig. 4. Light microscopy showing a glomerulus with a crescent associ-
ated with a gap in the basal lamina of Bowman's capsule (arrow).
(Periodic-acid-Schiff, x 300)
where 1 + involvement of < 20% of the area available for
study, 2 + = 20 to 50%, and 3 + = > 50% of the area.
Immunofluorescence (IF) findings in 44 biopsy specimens
were obtained from the original biopsy reports. Specimens for
IF were snap-frozen and stained by the direct method using
fluoresceinated antisera monospecific for IgG, 1gM, IgA, and
C3, Cl, or C4, and fibrinogen-related antigen (FRA). Sources of
the antisera varied, but the majority of the submitting institu-
tions utilized reagents from Meloy Lab, Inc., Springfield,
Virginia, USA.
Electron microscopy (EM) findings were obtained and com-
piled from selected prints and the accompanying diagnostic
reports in 45 of the 50 patients. Tissue samples were processed
for EM by each of the submitting institutions according to
accepted techniques as described in a previous SPNSG study
[15].
Statistical methods
Correlations were sought between the clinical and pathologic
features listed in Table 1, and results are expressed in the text
and tables as mean 1 standard deviation (SD), unless other-
wise stated. The statistical methods utilized included
Spearman's correlation coefficient, x2 contingency table analy-
sis, and Fisher's exact probability test where each of these was
appropriate. Comparisons were made with unpaired Student's t
tests or analysis of variance for three or more groups. Statistical
significance was defined as a P value less than or equal to 0.05.
It should be noted, however, that in some instance there was
only a small number of data points available for analysis. In
these cases, the failure to demonstrate a significant correlation
does not necessarily mean that such a relationship does not
exist.
Results
Fifty patients (30 girls and 20 boys) satisfied criteria for
acceptance into the study. Their ages ranged from 1.7 to 17.2
years (mean, 10.1 4.0 years) with 53% whites, 21% blacks,
and 17% hispanics in the total group. The patients had a variety
of underlying conditions or "diseases" (Table 2). The six
patients listed as poststreptococcal glomerulonephritis had cul-
ture or serologic evidence of streptococcal infection and were
hypocomplementemic. Subepithelial humps in five patients and
intense staining for C3 along glomerular capillary walls in the
other patient constituted good pathologic evidence for this
diagnosis. Three of the patients listed as exhibiting nonspecified
immune complex disease had no history compatible with
postinfectious GN but were also hypocomplementemic. It is
apparent from Table 2 that the patient population was hetero-
geneous in its makeup, with relatively few patients in each
"type." Comparison between disease groups was therefore
difficult but was performed where patient numbers permitted.
Initial clinical and laboratory features
These features will be described for the 50 patients as a
whole, and separately for the 18 patients with 50 to 79%
crescents, group 1, and 32 patients with 80 to 100% crescents,
group 2 (Table 3).
Hypertension. The overall frequency of hypertension was
51% when recorded during the presenting phase of the disease
course. Comparison of this variable between patient subgroups
revealed a rather striking disparity with the frequency being
17% in group 1 versus 73% in group 2, (P < 0.0001). This
difference persisted up to the time of renal biopsy (28% versus
65%, P = 0.002). The mean blood pressures at the time of
presentation were 115/71 mm Hg in group I and 138/91 mm Hg
in group 2.
Hematuria. Microscopic hematuria was present in 100% of
the patients at the time of clinical presentation; in 73% of them
the hematuria was gross. When this feature was compared
between the two groups, the frequency of gross hematuria was
identical (73%). At the time of biopsy, 66% of all patients had
gross hematuria.
Proteinuria and nephrotic syndrome. At the time of presenta-
tion, moderate to severe proteinuria (3 to 4+) was present in
78% of the total group and in 72 and 81%, respectively, of
subgroups 1 and 2 (P = 0.68). The severity of the proteinuria
was not quantitated accurately in sufficient numbers for mean-
ingful analysis, but the degree of hypoalbuminemia was identi-
cal in the two groups (mean serum albumin, 2.6 g/dl). Edema
TV
e!
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Table 3. Selected clinical and laboratory features in 50 children with crescentic glomerulonephritis
Features All patients
Group 1
(50 to 79% crescents)
Group 2
(80% or more crescents)
P value
(1 vs. 2)
Number of patients 50 18 32
Age at presentation 1.7 to 17.2 years
(mean, 10.1 years)
2 to 15 years
(mean, 9.7 years)
2 to 17 years
(mean, 10.5 years)
0.50
Hypertension at presentation 51% 17% 73% 0.0002
Serum creatinine at presentation 5.2 5.7 3.0 2.3 6.6 6.7 0.02
GFR at presentation 42 8 62 61 27 33 0.05
Poor outcome (endstage) 23/47 (48%) 8/18 (44%) 15/29 (52%) 0.77
was noted during the initial presentation in 61% overall and in
53% of group 1 and 66% of group 2 patients (P = 0.53). The
severity of the proteinuria, hypoalbuminemia, and edema were
also similar in the two groups at the time of biopsy.
Renal function. At presentation, the mean GFR (mllminll.73
m2) for the entire group was 41.8 49.4, with the majority
(86%) having some depression of GFR (less than 90) and most
(66%) having a more marked fall (less than 30). Comparison of
groups 1 and 2 revealed that patients with crescent formation in
80% or more glomeruli (group 2) had a lower GFR (27.0 33.0)
than patients with 50 to 79% crescents (group 1, 62.0 61.2, P
= 0.05). The percentage of patients with GFR less than 10
mllmin/l.73 m2 was also higher in group 2 (18% vs. 6% in group
1). This difference in GFR persisted up to the time of biopsy.
Other laboratory features. Low C3 was present in 54% of
group 1 patients and 45% of group 2 patients (P = 0.73).
Serologic evidence of previous streptococcal infection (el-
evated anti-streptolysin 0 titer or streptozyme) was present in
34% of the total group and tended to be more frequent in
patients with extensive crescent formation (group 1, 17%; group
2, 45%; P 0.13).
Subsequent clinical course and outcome
The frequency of renal insufficiency progressing to ESRD in
the overall group was 49% (23 of 47) in patients where followup
was available. During the latest followup, persistent elevation
of blood pressure was noted in only 17% of the remaining 24
patients, and hematuria was also uncommon at that time being
noted in only one of 23 patients. In contrast, 20% of the patients
with maintenance of renal function had persistent 3 to 4+
proteinuria and 48% (12 of 25) had 2 + or greater proteinuria.
The frequency of 3 to 4 + proteinuria was not different in the
two groups (P = 0.30), whereas 2 + proteinuria tended to be
present more frequently in group 2.
Estimated GFR was normal at latest followup in 13 of 47
(28%) overall, with no difference being noted between group 1
(5 of 18, 28%) and group 2 (8 of 29, 28%). Similarly, the
percentage of patients with GFR greater than 60 mllmin/l .73 m2
at followup (18 of 47; 39%) was equal in the two groups (7 of 18
and 11 of 29, or 39 and 38%, respectively). Conversely, a
significant difference was noted with respect to GFR greater
than 60 mllmin/1 .73 m2 at followup when patients with definite
poststreptococcal glomerulonephritis (5 of 5, 100%) were com-
pared to the rest of the patients (12 of 41, 29%; P = 0.005).
Treatment
Prior to renal biopsy, corticosteroids, cytotoxic agents, and
anticoagulants were given to 42, 15, and 5% of the patients,
respectively. No difference in the frequency of prior
corticosteroid therapy was seen when patients with less than or
greater than 80% crescents were compared (44 and 41%,
respectively). Following the diagnostic renal biopsy, 66% of the
patients were given steroids, 44% cytotoxic agents, and 34%
anticoagulants. Patients with more extensive crescents (group
2) were given anticoagulants more frequently than group 1
patients (42% vs. 21%), but no differences were noted with
respect to treatment with steroids or cytotoxic agents.
Pathologic studies
Light microscopy. The mean percentage of glomeruli with
crescents in the 50 patients was 82%. Of these, 20% were small,
29% were medium-sized, and 51% were large. Thirty-seven
percent of the crescents were cellular, 51% were fibrocellular,
and 12% were fibrous. Crescents in different stages of formation
(that is, cellular, fibrocellular, and fibrous) were evident in 38%
of all cases. Regions of fibrin and/or necrosis in crescents were
seen in 26 biopsy specimens and polymorphonuclear leukocytes
(polys) in 29 specimens. Eighteen biopsy specimens showed
both necrosis and polys in the crescents, a feature that was
usually seen in cellular crescents rather than fibrocellular or
fibrous crescents (Table 4).
Gaps in Bowman's capsule were only seen in the presence of
crescents. They were observed in 51% of all glomeruli with
crescents from the total series of 50 patients, and in 16% of all
cellular crescents, 66% of all fibrocellular crescents, and 16% of
all fibrous crescents. When analyzing the individual biopsy
specimens, gaps in Bowman's capsule were observed in 48 of
the 50 biopsy specimens (96%), and were associated with
cellular crescents in 17 of the 40 biopsy specimens in which
cellular crescents were observed, with fibrocellular crescents in
all 42 specimens containing fibrocellular crescents (100%), and
with fibrous crescents in 20 of the 26 biopsy specimens contain-
ing fibrous crescents (77%). The two specimens not containing
gaps in Bowman's capsule had only cellular crescents. The gaps
in Bowman's capsule were often contiguous with an interstitial
mononuclear cell infiltrate. Fibrin and fibroblasts were also
seen next to the gaps in the interstitium and inside the cres-
cents. In some glomeruli more than one gap was observed.
Areas of thinning and lamination were also seen in Bowman's
capsule in some cases.
Glomerular tuft hypercellularity, which was observed in 70%
of biopsy specimens, was most prominent in patients with
systemic lupus erythematosus (SLE), dense deposit disease
(DDD), Henoch-SchOnlein purpura (HSP), poststreptococcal
GN, nonspecified immune complex disease (lCD) with low C3,
and IgA nephropathy but present rarely in biopsy specimens
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Table 4. Selected pathologic features in 50 children with crescentic glomerulonephritisa
Features All patients
Group I
(50 to 79% crescents)
Group 2
(80% or more crescents)
P value
(1 vs. 2)
No. of glomeruli in each case 22 17
(5—100)
23 13
(6—51)
21 19
(5—100)
0.59
% of glomeruli with crescents 82 14
(50—100)
67 10
(50—79)
90 8
(80—100)
0.0001
% of glomeruli with large crescents 51 26
(0—100)
42 27
(0—90)
55 26
(0—100)
0.10
% of glomeruli with LFC crescents 27 23
(0—88)
19 17
(0—50)
32 25
(0—88)
0.08
% of glomeruli with gaps in Bowman's capsule 51 30
(0—100)
54 31
(0—100)
49 31
(0—100)
0.61
% of gaps in glomeruli with FC crescent 66 33
(0—100)
53 32
(0—100)
74 31
(0—100)
0.04
% of glomeruli with glomerulosclerosis 12 20
(0—94)
14 18
(0—64)
11 20
(0—94)
0.68
Abbreviations: LFC, large fibrocellular crescent; FC, fibrous crescent.
a Results are expressed as mean SD (range).
showing vasculitis or no evidence of immunecomplex disease.
Polymorphonuclear leukocytic infiltrates were found in the
glomeruli in 60% of biopsy specimens and were most frequent
in patients with DDD, lCD with low C3, poststreptotoccal GN,
SLE, HSP, and crescentic GN with no lCD. No glomerular
poiys were noted in patients with vasculitis, IgA, or the three
cases of possible anti-GBM. Increased glomerular lobulation
was observed in 32% of biopsy specimens and was most
frequently found in patients with SLE (7 of 9).
Mild to moderate thickening of the glomerular capillary walls
was observed in 30% of the cases and was most frequent in
cases of DDD (2 of 2) and SLE (7 of 9). Gaps of glomerular
basement membranes were observed in only six cases; no
association with any underlying disease category was found.
Focal glomerular necrosis was observed in eight cases of
variable disease types and was often associated with the pres-
ence of polymorphonuclear leukocytes. Global glomeruloscler-
osis (greater than 10% of glomeruli showing global sclerosis)
was noted in 32% of cases, but only three cases showed
sclerosis of greater than 50% of the glomeruli.
Tubular atrophy, which was often mild and associated with
focal interstitial fibrosis, was observed in 94% of cases. Biopsy
specimens with the most prominent tubular atrophy were
associated with more severe global glomerulosclerosis. Inter-
stitial infiltration of mononuclear cells was evident in all but one
biopsy. Vasculitis was evident in the renal tissue of only one of
three patients clinically diagnosed with vasculitis (demon-
strated in extra-renal tissues of the other two patients) and in
one patient with Henoch-SchOnlein purpura. Arterial and arteri-
olar sclerosis were present, albeit mild, in ten patients. No
differences were noted in the tubulointerstitial or vascular
changes between groups 1 and 2.
Immunofluorescence (IF) studies. IF was performed on 44
renal biopsy specimens. IgG was present in 57%, IgA in 43%,
1gM in 54%, C3 in 82%, Cl or C4 in 44%, and FRA in 27% of the
biopsy specimens. The IF pattern in the majority of the cases
was granular and localized in the glomerular mesangium and/or
basement membranes. A diffuse linear reaction for IgG was
described along the glomerular capillary walls in three patients.
In two biopsy specimens no immunoreactant was observed
except for traces of 1gM and C3. Immunoreactants were not
present in one specimen. FRA in glomerular crescents was
present in 16 of 17 biopsy specimens where this was recorded.
Overall, the IF findings were consistent with those expected for
the underlying glomerulopathies.
Electron microscopic (EM) studies. Forty-five biopsy speci-
mens were studied by EM. In 33(73%) discrete "immune-type"
electron dense deposits were identified (subepithelial deposits
in 20 biopsy specimens, subendothelial in 15, mesangial in 25,
and intramembranous in 18 biopsy specimens). Large sub-
epithelial deposits ("humps") were evident in five of six pa-
tients with postinfectious GN. The presence of electron dense
fibrillar fibrin in the glomerular tuft or amid crescent formations
was noted in nine biosy specimens. As noted for the IF studies,
the EM in each renal biopsy was consistent with the changes
expected as a result of the underlying glomerulonephropathy.
Evaluation of individual pathologic features in the total group
revealed a large number of significant correlations. Table 5
summarizes the most important of these intrapathological cor-
relations. One of the most interesting correlations was seen
between gaps in the Bowman's capsule and the percentage of
crescents that were either fibrous or fibrocellular (r = 0.575, P
<0.001). This relationship is depicted in Figure 5.
Clinico-pathologic correlations
The frequency of cellular crescents showed a positive cor-
relation with hypertension (P < 0.05) and gross hematuria (P =
0.03) at initial presentations. There was also a significant
correlation between low GFR at the time of biopsy and large
size (P = 0.006) and increased numbers of cellular crescents (P
= 0.05). Another correlation existed between lower serum C3
with glomerular lobulation (P = 0.02) and subepithelial humps(P = 0.02). The finding of periphertl edema was correlated with
the amount of interstitial edema in the biopsy (P = 0.002).
Indicators of poor outcome
A poor outcome was associated with a high percentage of
large crescents (P = 0.004), cellular crescents (P = 0.009),
fibrous crescents (P = 0.03), the percentage of glomeruli with
Bowman's capsule gaps (P = 0.004), presence of 1gM deposi-
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Table 5. Intrapathologic correlations between selected pathologic features in crescentic glomerulonephritis
Feature Feature P value
Large crescents with Percentage of glomeruli with crescents (any type) 0.001
Large crescents with Percentage of glomeruli with fibrous or fibrocellular
crescents
0.001
Small crescents with Percentage of glomeruli with cellular crescents 0.01
Necrosis in crescents with Percentage of glomeruli with cellular crescents 0.02
Necrosis in crescents with Presence of FRA by IF in crescents 0.04
Percentage of glomeruli with gaps in Bowman's
capsule
with Percentage of glomeruli with large crescents 0.001
Percentage of glomeruli with gaps in Bowman's
capsule
with Percentage of glomeruli with fibrocellular and/or fibrous
crescents
0.001
(Both)
Glomerular tuft hypercellularity with Mesangial EM deposits 0.04
Glomerular tuft hypercellulanty with Subendothelial EM deposits 0.001
Glomerular lobulation with Mesangial EM deposits 0.02
Polymorphonuclear leukocytes in glomerular tufts with Subepithelial EM deposits 0.06
Global glomeruloscierosis with Glomerular tuft 1gM by IF 0.02
Global glomeruloscierosis with Interstitial fibrosis 0.03
75 100
Crescents with fibrous transformation,
% of total
Fig. 5. Relationship between frequency of gaps in the Bowman's
capsule and the percentage of total crescents showing fibrous or
fibrocellular changes.
tion in glomeruli (P = 0.003), deposition of FRA in glomeruli (P
0.02), global glomerulosclerosis (P 0.05), interstitial
fibrosis (P = 0.03), and tubular atrophy (P = 0.04).
There was no correlation between the presence of gross
hematuria at any time during the disease course and the
subsequent outcome of the patients. Thus, it appears that
hematuria was associated with early stages of crescent forma-
tion but was not indicative of the ultimate severity of glomerular
damage. Comparison of the severity of proteinuria with clinical
outcome did not reveal a significant correlation. This was not
surprising, however, since moderate to severe proteinuria was
so common in all patient groups.
None of the other clinical or laboratory variables was predic-
tive of outcome.
Discussion
In studies of crescentic glomerulonephritis the definition of a
crescent is crucial in determining the numbers of crescents and
how they correlate with other pathologic and clinical features—
particularly in terms of patient survival. Some previous studies
have included patients who have only 25 to 30% of glomeruli
involved with crescent formation, whereas others have required
50, 70, or 80% of glomeruli to have crescents. In this study, we
have evaluated children with renal biopsy specimens in which
50% or more of the glomeruli contained small, medium, or large
crescents and have carefully defined the types of crescents that
have been studied.
The clinical outcome of patients in our study was similar to
that described by other authors with approximately half of them
progressing to endstage renal disease [3—6, 9]. Although the
presence of crescents in 80% or more glomeruli has been
considered a grave prognostic sign [2, 3], we found no evidence
to support the concept that subcategorization of patients with
more than 50% glomerular involvement has any prognostic
significance. However, it is of interest to note that patients with
the most crescents ( 80%) did have more severe renal in-
sufficiency and hypertension during the initial presentation.
Although the number of crescents beyond 50% did not prove
to be a useful outcome indicator, there were a number of other
histopathologic features that appeared to be of predictive value.
.
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These included (1) predominance of large crescents; (2) in-
creased frequency of fibrous transformation in the crescents; (3)
large numbers of gaps in Bowman's capsule; (4) global glomeru-
losclerosis; (5) the presence of glomerular tuft 1gM; (6) the
severity of interstitial fibrosis. Most, if not all, of these findings
are probably indicative of the severity of the initial renal insult
and the probable irreversibility of the morphologic lesions. The
effect of therapy on the outcome of our patients is difficult to
assess because of the multitude of the underlying glomerular
disorders, the retrospective nature of the study, and the conse-
quent lack of standardization of treatment.
Previous studies have shown that a variety of histologic
changes may occur within the glomerular tuft in biopsy speci-
mens with crescentic GN; some authors have suggested that
intracapillary hypercellularity is more likely to be seen in those
patients with an immune-complex type of crescentic GN and be
associated with less risk of progressive renal dysfunction [8]. In
our study, glomerular tuft hypercellularity was most commonly
seen in association with glomerular mesangial deposits by EM,
low serum complement, and immune-complex crescentic GN,
but was not found to be a helpful indicator of outcome.
Discontinuities in the GBM have been demonstrated in
patients with crescentic GN by a number of authors [18, 19] and
have been implicated in the formation of crescents via the
passage of large amounts of cells and clotting factors into the
Bowman's space. In our study such changes were identified in
only six biopsy specimens. In addition, large gaps in the basal
lamina of the Bowman's capsule have been described in both
humans [20—22] and experimental models [23] of crescentic GN.
According to Morita, Suzuki, and Churg [22], these gaps were
infrequent; however, Olsen [21] found them in approximately
one-half of the biopsy specimens. In our study, 96% of the
biopsy specimens showed Bowman's capsule gaps. It is pos-
sible that these gaps may allow nearby interstitial inflammatory
cells and fibroblasts to enter into and contribute to the cellular-
ity of the crescents. In addition, cells of the monocyte-macro-
phage series may be responsible for the generation of factor(s)
that stimulate fibroblasts to increase their rate of collagen
synthesis [24—27]. Movement of such mononuclear cells into
Bowman's space might stimulate pericapsular interstitial
fibroblasts to migrate inward through the Bowman's capsule
gaps with subsequent transformation of the cellular crescent
into a fibrocellular or fibrous crescent. Indeed, gaps in
Bowman's capsule were closely associated with the fibrocel-
lular stage of crescent formation. The fact that these gaps were
also seen in association with the cellular crescents suggests that
the gaps precede the fibrocellular stage of the crescents. These
capsular gaps could be related to immunologic reactions similar
to those occurring along the GBMs and/or to compression and
destruction due to crescent formation, fibrin, or other injurious
agents.
The significance of extracapillary proliferation in children
with poststreptococcal glomerulonephritis has remained con-
troversial; a number of reports has dealt with this issue [5, 7, 9,
101. In a recent comprehensive review of the natural history of
glomerulonephritis, Cameron [1] described the actuarial sur-
vival of patients with severe crescentic glomerulonephritis
based on the experiences of himself, Habib, Kincaid-Smith, and
Morel-Maroger. He concluded that the prognosis of such pa-
tients (with all forms of nephritis) is "almost entirely dependent
on the large numbers of crescents and that the prognosis
normally associated with the underlying glomerular disease is
no longer operative, because the prognosis of the crescent
formation is so bad." He also furthered the argument that the
apparently good prognosis in patients who had poststreptococ-
cal glomerulonephritis with extensive crescents has been mis-
represented because most of the patients in this group have had
relatively minor degrees of crescent formation. In the present
study, six patients with poststreptococcal glomerulonephritis
and crescent formation in 51, 60, 87, 90, 92, and 100% of the
glomeruli were identified. The crescents were generally cellular
rather than fibrocellular or fibrous and there was a low percent-
age of large crescents with little evidence of chronic histologic
changes such as global glomerulosclerosis and interstitial fi-
brosis. It is likely that in the absence of progressive injury to the
glomerulus that these cellular crescents may resolve without
major sequelae [28, 29]. Indeed all five patients with good
followup have normal GFRs at the latest evaluation, irrespec-
tive of whether treatment was given. We conclude from the data
in these patients that well-documented poststreptococcal gb-
merulonephritis in children is a self-limited disorder with an
excellent clinical outcome. The study of Roy, Murphy, and
Arant [7] would further suggest that this outcome is unaffected
by therapeutic intervention and that such patients should re-
ceive only supportive measures to control the consequences of
their renal insufficiency, hypertension, and so forth, until a
spontaneous remission occurs.
In this study we also had nine pediatric patients with cres-
centic GN associated with SLE. Eight of the biopsy specimens
demonstrated diffuse proliferative glomerulonephritis and the
other case had membranous glomerulonephropathy. All cases
had moderate to severe hypercellularity of the glomerular tuft
with polys being present in all but one case. Mesangial electron
dense deposits were observed in eight of nine cases, sub-
endothelial deposits in seven of nine, and subepithelial deposits
in seven of nine cases. The outcome in these cases was not
related to the number of crescents since three of four patients
from group I and two of five from group 2 developed endstage
renal disease. This supports the concept that the prognosis in
patients with more than 50% glomerular crescents is not di-
rectly related to the number of crescents.
We would conclude from our studies that approximately 50%
of children with a renal biopsy showing crescents in 50% or
more glomeruli progress to endstage renal disease. We have no
evidence to suggest that further subcategorization of these
patients based on the percent involvement is predictive of
outcome. On the other hand, the excellent clinical outcome of
patients with well defined poststreptococcal crescentic gb-
merubonephritis suggests that such patients should be treated
symptomatically and that they may have an excellent chance
for recovery. Finally, our studies have provided considerable
evidence that there is a strong association between fibrocellular
crescents and gaps in Bowman's capsule and suggest that the
fibrous transformation of crescents may in large part be related
to gaps in the Bowman's capsule and possibly the passage of
proteins and cells from the renal interstitium to Bowman's
space across points of rupture in Bowman's capsule.
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